Concepedia

Eric Holmgren

EH

Statistics

Publications

35

Citations

17.4K

H-Index

28

Active since

1995

Affiliations

Sarah Cannon(Current)

Duke University

Kaiser Permanente

The University of Texas MD Anderson Cancer Center

Duke Medical Center

Eric Holmgren is an author at Sarah Cannon specializing in medicine, pharmacology, and oncology.

Publications per year

1995–2023

35

Publications

35

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny et al. · New England Journal of Medicine · 2004 · 11K citations · Full text

, , +15

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

David H. Johnson, Louis Fehrenbacher, William Novotny et al. · Journal of Clinical Oncology · 2004 · 1.9K citations · Full text

, , +11

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

Michael S. Gordon, Kim Margolin, Moshe Talpaz et al. · Journal of Clinical Oncology · 2001 · 919 citations

, , +17

Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, John D. Hainsworth et al. · Journal of Clinical Oncology · 2005 · 685 citations

, , +13

Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer

Adrian M. Jubb, Herbert I. Hurwitz, Wei Bai et al. · Journal of Clinical Oncology · 2005 · 389 citations · Full text

, , +17

1–5 of 35